VMD NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Viemed Healthcare Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 11.77 USD
-3.1% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 24.4% above the Trend Line and sits at 87.4% of its 52-week range. The latest completed week returned -3.1%, after a 1.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 55/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 69 out of 100
Latest Close 11.77 USD 24 Jul 2026
1W Return -3.1% latest completed week
4W Return 1.2% short-term follow-through
12W Return 18.1% quarterly tape
Trend Breadth 65.4% 34 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 33-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.1% Latest completed week; four-week move 1.2%. Indicator stack 81/86 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 55/100 conviction; expected move 26.6%. News sentiment 52/100 73 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 24.4% above the Trend Line and sits at 87.4% of its 52-week range. The latest completed week returned -3.1%, after a 1.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9412-week average 0.88

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.94Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.2% over four weeks, 18.1% over 12 weeks, and 92.3% over one year. The current trend has remained active for 33 consecutive weeks.

Performance by holding period

1W-3.1%
4W1.2%
12W18.1%
26W60.8%
52W92.3%
Active trend streak33 weeks
Active weeks in one year34
Trend breadth65.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.42Latest activity-pressure read.
Pressure change133.0%Four-week change in activity pressure.
Leadership30.31Latest relative-leadership reading.
RS change5.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength93/100Blend of value, momentum, and quality. Underlying universe rank 8; rank 1 is best.
Value70/100Relative valuation strength. Underlying universe rank 31; rank 1 is best.
Quality86/100Profitability and accounting quality. Underlying universe rank 15; rank 1 is best.
Momentum94/100Medium-term price momentum. Underlying universe rank 7; rank 1 is best.
Growth35/100Revenue and earnings growth. Underlying universe rank 66; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework47/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
30.3x
Price divided by trailing earnings.
Price / sales
1.6x
Market value relative to trailing revenue.
EV / EBITDA
8.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
19.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
57.3%
Gross profit retained from each unit of revenue.
Operating margin
8.2%
Operating profit retained from revenue.
Free-cash-flow margin
30.8%
Free cash flow generated from revenue.
Return on invested capital
11.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
23.1%
Latest one-year revenue growth.
EPS growth
21.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
0.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
3.3%
Net share repurchases relative to market value.
Shareholder yield
3.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

VMD shows volatility options pressure with a 55/100 conviction score, put-call volume ratio of 0.00, expected move of 26.6%, and Sharemaestro trend signal active.

Conviction55/100
Expected move26.6%
Put/call volume0.00
Pressure100
Speculation9
Volatility96
Trend agreement4
Open options detail
Insider activity1 / 7

1 acquisitions and 7 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 73 relevant articles.

12 positive · 57 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move26.6%Nearest-chain priced movement where available.
52-week drawdown-6.7%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher18 of 268 weeks finished lower.
Best week+12.6%Week of 6 Feb.
Worst week-10.3%Week of 8 May.
Latest week-3.1%Week of 24 Jul.

Shape of recent returns

Strong gains9
Modest gains9
Flat weeks0
Modest losses5
Sharp losses3
Recent vol4.5%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew4.3% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape71/100

Trend, activity pressure, participation, and risk combine to a 71/100 tape read.

 Indicator analysis81/100

Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 11/12.

Activity pressure 0.94; 3 reversal markers Factors85/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 17; Small Cap Core rank 36 SVQF47/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 385.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options37/100

VMD shows volatility options pressure with a 55/100 conviction score, put-call volume ratio of 0.00, expected move of 26.6%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 26.6% Sentiment52/100

Weighted news tone is neutral across 73 relevant articles.

Enterprise value to EBIT forward of Viemed Healthcare, Inc. – NASDAQ:VMD Insiders1 / 7

1 acquisitions and 7 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202611.77 USD-3.1%9.46 USD7.89 USD1.4230.311.3MOn
17 Jul 202612.15 USD-1.3%9.31 USD7.87 USD1.5733.601.7MOn
10 Jul 202612.31 USD2.4%9.15 USD7.85 USD1.2930.861.5MOn
3 Jul 202612.02 USD3.4%8.98 USD7.83 USD0.9831.021.4MOn
26 Jun 202611.63 USD9.3%8.81 USD7.81 USD0.6128.622.6MOn
19 Jun 202610.64 USD1.8%8.65 USD7.80 USD0.2113.021.3MOn
12 Jun 202610.45 USD4.8%8.52 USD7.79 USD0.0614.27980.5KOn
5 Jun 20269.97 USD1.3%8.38 USD7.78 USD-0.0211.85946.7KOn
29 May 20269.84 USD2.0%8.26 USD7.78 USD0.105.65894.8KOn
22 May 20269.65 USD3.2%8.15 USD7.78 USD0.506.681.1MOn
15 May 20269.35 USD4.6%8.06 USD7.78 USD0.854.751.4MOn
8 May 20268.94 USD-10.3%7.97 USD7.79 USD1.25-0.141.9MOn
1 May 20269.97 USD3.2%7.90 USD7.80 USD1.5917.411.2MOn
24 Apr 20269.66 USD-0.8%7.80 USD7.80 USD1.6215.46836.9KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.